C.M. Bidwell & Associates’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Buy
1,321
+169
+15% +$28.2K 0.08% 148
2026
Q1
$242K Sell
1,152
-3
-0.3% -$754 0.11% 119
2025
Q4
$328K Sell
1,155
-34
-3% -$10.6K 0.16% 82
2025
Q3
$367K Sell
1,189
-55
-4% -$17.2K 0.18% 78
2025
Q2
$391K Sell
1,244
-62
-5% -$17.9K 0.2% 76
2025
Q1
$343K Sell
1,306
-23
-2% -$6.22K 0.21% 82
2024
Q4
$347K Sell
1,329
-45
-3% -$11.3K 0.21% 80
2024
Q3
$320K Buy
1,374
+295
+27% +$60.6K 0.2% 81
2024
Q2
$218K Sell
1,079
-709
-40% -$128K 0.15% 109
2024
Q1
$306K Buy
1,788
+1
+0.1% +$186 0.21% 85
2023
Q4
$388K Buy
1,787
+1,130
+172% +$194K 0.29% 67
2023
Q3
$105K Sell
657
-142
-18% -$31.8K 0.08% 221
2023
Q2
$230K Buy
799
+458
+134% +$139K 0.17% 110
2023
Q1
$109K Buy
+341
New +$101K 0.08% 219
2018
Q1
Sell
-2,730
Closed -$188K 429
2017
Q4
$188K Buy
+2,730
New +$179K 0.16% 176

Other funds holding PODD

C.M. Bidwell & Associates's PODD Position: Q2 2026 in Review

C.M. Bidwell & Associates increased its Insulet (PODD) stake by 15% in Q2 2026, buying an estimated $28.2K and bringing the position to 1,321 shares worth $201K. The position accounts for 0.08% of the portfolio, ranked #148.

C.M. Bidwell & Associates first reported a position in PODD in Q4 2017 and has held it in 15 quarters since. The position peaked at $391K in Q2 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • C.M. Bidwell & Associates held 1,321 shares of Insulet worth $201K as of Q2 2026.
  • C.M. Bidwell & Associates bought 169 Insulet shares in Q2 2026, an estimated $28.2K.
  • Insulet made up 0.08% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #148 holding.
  • C.M. Bidwell & Associates first reported a position in Insulet in Q4 2017 and has held it in 15 quarters since.
  • C.M. Bidwell & Associates's Insulet position peaked at $391K in Q2 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.